BCL2 and breast cancer: Our present study clearly shows that DMF induces apoptosis through decreased Survivin, XIAP, Bcl-xL, and Bcl-2 expression via inhibition of NF-κB activation and potentiates the apoptosis-inducing effect of adriamycin and paclitaxel in human breast cancer cells.